Neuroendocrine modulation of immune system

Indian Journal of Pharmacology

Volumn 30, Issue 3, 1998, Pages 129-140

  Dan, G ^a   Lall, S B ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Lymphocytes; Lymphokines; Neuroendocrinology; Neuropeptides

Indexed keywords

CORTICOSTEROID; CORTICOTROPIN; CYTOKINE; ESTROGEN; GROWTH HORMONE; INTERLEUKIN 1; NERVE GROWTH FACTOR; NEUROPEPTIDE; NEUROTRANSMITTER; OPIATE PEPTIDE; OXYTOCIN; PEPTIDE HORMONE; PROGESTERONE; PROLACTIN; SEX HORMONE; SOMATOSTATIN; SUBSTANCE P; TESTOSTERONE; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOPRESSIN;

AUTOIMMUNE DISEASE; AUTONOMIC NERVOUS SYSTEM; B LYMPHOCYTE; HORMONE RELEASE; HORMONE SYNTHESIS; HUMAN; HYPOTHALAMUS; IMMUNE SYSTEM; IMMUNOMODULATION; NEUROENDOCRINE SYSTEM; NONHUMAN; REVIEW; SECOND MESSENGER; T LYMPHOCYTE; THALAMUS MIDLINE NUCLEUS;

EID: 0031858949     PISSN: 02537613     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (120)

1. Blalock JE. The syntax of immune-neuroendocrine communication, Immunol Today 1994;15:504-11.
2. Besedovsky HO. Del Rey A. Immune-Neuro-Endocrine Interactions: Facts and Hypotheses. Endocrine Rev 1996;17:64-102.
3. Cake MH, Litwack G. The glucocorticoid receptors. In; Litwack G (eds) Biochemical Actions of Hormones, vol 3. New York: Academic Press, 1975:317-90.
4. Werb Z, Foley R, Munck A. Interaction of glucocorticoids with macrophages. Indentification of glucocorticoid receptors in monocytes and macrophages. J Exp Med 1978;147:1684-94.
5. Helderman JH, Strom T. Specific insulin binding site on T and B lymphocytes as a marker of cell activation. Nature 1978;274:62-3.
6. Hollenberg MD, Cuatrecasa P. Hormone receptors and membrane glycoproteins during in vitro transformation of lymphocytes. In: Clarkson B, Baserga R (eds) Control of Proliferation of Animal Cells. New York: Cold Spring Harbor Laboratory, Cold Spring Harbor, 1974:423-34.
7. Hiesland P, Mekler P. Mechanism of action: cyclosporin and prolactin-mediated control of immunity. Prog Allergy 1986;38:239-46.
8. Russell DH, Matrision L, Kibler R, Larson D, Poulps B, Magun B. Prolactin receptor on human lymphocytes and their modulation by cyclosporin. Biochem Biophys Res Commun 1984;121:899-906.
9. Arrenbrecht S. Specific binding of growth hormone to thymocytes. Nature 1974;252:255-7.
10. Gillette S, Gillette R. Changes in thymic estrogen receptor expression following orchidectomy. Cell Immunol 1979;42:194-6.
11. Abraham AD, Bug G. 3H-testosterone distribution and binding in rat thymus cells in vivo. Mol Cell Biochem 1976;13:157-63.
12. Bourne HR, Lichtenstein LM, Melmon KL, Henney CS, Weinstein Y, Shearer GM. Modulation of inflammation and immunity by cyclic AMR Receptors for vasoactive hormones and mediators of inflammation regulate many leukocyte functions. Science 1974;184:19-28.
13. Hadden JW, Hadden EM, Middleton EJ. Lymphocyte blast transformation.I. Demonstration of adrenergic receptors in human peripheral lymphocytes Cell Immunol 1970;1:583-95.
14. Landmann RMA, Bittiger H, Buhler FR. High affinity beta-2 adrenergic receptors in mononuclear leucocytes: similar density in young and old normal subjects. Life Sci 1981;29:1761-71.
15. Landmann RMA, Wesp M, Box R, Keller U, Buhler FR. Distribution and function of beta-adrenergic receptors in human blood lymphocytes. In: Hadden JW, Masek K, Nistico G (eds) Interactions among CNS, Neuroendocrine and Immune systems. Rome: Pythagora Press 1989:251-64.
16. Singh U, Millson DS, Smith PA, Owen JJT. Identification of beta-adrenoceptors during thymocyte ontogeny in mice. Eur J Immunol 1979;9:31-5.
17. Richman DP, Arnason BG. Nicotinic acetylcholine receptor evidence for a functionally distinct receptor on human lymphocytes. Proc Natl Acad Sci USA 1979;76:4632-5.
18. Strom TB, Sytkowkski AJ, Carpenter CB, Merrill JP. Cholinergic augmentation of lymphocyte-mediated cytotoxicity. A study of the cholinergic receptor of cytotoxic T lymphocytes. Proc Natl Acad Sci USA 1974;71:1330-3.
19. Hazum E, Chang KJ, Cuatrecasas P. Specific nonopiate receptor for beta endorphins. Science 1979;205:1033-5.
20. Wybran J, Appelboom T, Famaey JP, Govaerts A. Suggestive evidence for morphin and methionine-enkephalin receptor-like structures on normal blood T lymphocytes. J Immunol 1979;123:1068-70.
21. Payan D, Brewster D, Missirian-Bastian A, Goetzl E. Substance P recognition by a subset of human T lymphocyte. J Clin Invest 1984;74:1532-9.
22. Stanisz A, Scicchitano R, Payan D, Bienenstock J. In vitro studies of immunoregulation by substance P and somatostatin. Ann N Y Acad Sci 1987;496:217-25.
23. Ottaway CA. Vasoactive intestinal peptide and immune function. In: Ader R, Felten D, Cohen N (eds) Psychoneuroimmunology, ed 2. New York: Academic Press Inc, 1991:225-62.
24. Cunningham JR ET, Wada E, Carter DB, Tracey DE, Battey JF, De Souza EB. In situ histochemical localization of type I interleukin-1 receptor messenger RNA in the central nervous system, pituitary, and adrenal gland of the mouse. J Neurosci 1992;12:1101-14.
25. De Souza EB, Webster EL, Grigoriadis DE, Tracey DE. Corticotropin-releasing factor (CRF) and interleukin-1 (IL-1) receptors in the brain-pituitary-immune axis. Psychopharmacol Bull 1989;25:299-305.
26. Ban E, Milon G, Prudhomme N, Fillion G, Haour F. Receptors for interleukin-1 (alpha and beta) in mouse brain: mapping and neuronal localization in hippocampus. Neuroscience 1991;43:21-30.
27. Bulloch K, Moore RY. Innervation of the thymus gland by brain stem and spinal cord in mouse and rat. Am J Anat 1981;162:157-66.
28. Reilly FD, McCuskey RA, Miller ML, McCuskey RS, Meineke HA. Innervation of the periateriolar lymphatic Sheath of the spleen. Tissue Cell 1979;11:121-6.
29. Williams JM, Felten DL. Sympathetic innervation of murine thymus and spleen: a comparative histofluorescence study. Anat Rec 1981;199:531-42.
30. Weihe E. Molecular anatomy of the neuroimmune communication, Int J Neurosci 1991;59:1-23.
31. Galant SP, Remo RA. Beta-adrenergic inhibition of human T lymphocyte rosettes. J Immunol 1975;114:512-3.
32. Hammerling U, Chin AF, Abbott J, Scheid MP.The ontogeny of murine beta lymphocytes. Induction of phenotypic conversion of la-to Ia+ lymphocytes. J Immunol 1975;115:1425-31.
33. Henney CS, Bourne HR, Lichtenstein LM. The role of cyclic 3,5-adenosine monophosphate in the specific cytolytic activity of lymphocytes. J Immunol 1972;108:1526-34.
34. Ito M, Sless F, Parrott DMV. Evidence for control of complement receptor rossette forming cells by alpha and beta adrenergic agents. Nature 1977;266:633-5.
35. MacManus JP, Boynton AL, Whitfield JF, Gillan DJ, Isaacs RJ. Acetylcholine induced initiation of the thymic lymphoblast DNA synthesis and proliferation. J Cell Physiol 1975;85:321-30.
36. StromTB, Deisseroth A, Morgan-Roth J, Carpenter CB, Merril JR Alteration of the cytotoxic action of sensitized lymphocytes by cholinergic agents and activators of adenylate cyclase. Proc Natl Acad Sci USA 1972;69:2995-9.
37. Besedovsky HO, Del Rey A, Sorkin E, Da Prada M, Keller HA. Immunoregulation mediated by the SNS. Cell Immunol 1979;48:346-55.
38. Miles L, Quintans J, Chelmicka-Schorr E, Arnason EGW. The SNS modulates antibody response to thymus independent antigens. J Neuroimmunol 1981,1:101-5.
39. Hall NR, Mc Clure JE, Hu SK,Tare NS, Seals CM, Goldstein AL. Effects of 6-hydroxy dopamine upon primary and secondary thymus dependent immune responses, Immuno Pharmacol 1982;5:39-48.
40. Livnat S, Fellen SY, Carlson SL, Bellinger DL, Felten DL. Involvement of peripheral and central catecholamine systems in neural immune interactions. J Neuro Immunol 1985;10:5-30.
41. Cook Mills JM, Cohen RL, Perlman RL, Chambers DA. Inhibition of lymphocyte activation by catecholamines: evidence for a non-classical mechanism of catecholamine action, Immunol 1995;85:544-9.
42. Murray DR, Irwin M, Rearden CA, Ziegler M, Motulsky H, Maisel AS. Sympathetic and immune interactions during dynamic exercise. Mediation via a beta 2-adrenergic dependent mechanism. Circulation 1992;86:203-13.
43. Spencer GS, Oliber MH. Suppression of immune response in lambs during treatment with the beta-adrenergic agonist clenbuterol. J Anim Sci 1996;74:151-3.
44. Pike JL, Smith TL, Hauger RL, Nicassio PM, Patterson TL, Mcclintic J et al. Chronic life stress alters sympathetic neuroendocrine and immune responsivity to an acute psychological stressor in humans.Psychosom Med 1997;59:447-57.
45. Campagnolo DI, Bartlett JA, Keller SE, Sanchez W, Oza R. Impaired phagocytosis of Staphylococcus aureus in complete tetraplegics. Am J Phys Med Rehabil 1997;76:276-80.
46. Dunn AJ. Psychoneuroimmunology for the psychoneuroendocnnologist: A review of animal studies of nervous system-immune system interactions. Psychoneuroendocrinol, 1989;14:251-74.
47. Maslinski W. Cholinergic receptors of lymphocytes. Brain Behavior Immunity 1989;3:1-14.
48. Demissie S, Rogers CF, Hiramoto NS, GhantaVK, Hiramoto RN. Arecoline a muscarinic cholinergic agent conditions central pathways that modulate natural killer cell activity. J Neuroimmunol 1995;59:57-63.
49. Yamada T, Murayama T, Nomura Y. Muscarinic acetylcholine receptors on rat thymocytes: Their possible involvement in DNA fragmentation. Jap J Pharmacol 1997;73:311-6.
50. Friedman EM, Irwin MR A role for CRH and the SNS in stress induced immunosuppression. Ann N Y Acad Sci. 1995;771:396-418.
51. Geenen V, Robert F, Defresne MP, Boniver J, Legros JJ and Franchimont P. Neuroendocrinology of the thymus. Hormone Res 1989;31:81-4.
52. Grossman A, Costa A, Forsling M, Jacobs R, Navarra P, Satta M. Immune modulation of the hypothalamo pituitary adrenal axis. Cytokines and gases in the hypothalamus. Ann N Y Acad Sci 1997;823:225-33.
53. Postel Vinay MC, DeMello Coelho V, Gagnerault MC, Dardenne M. Growth hormone stimulates the proliferation of activated mouse T lymphocytes. Endocrinol 1997;138:1816-20.
54. Yu Lee LY. Molecular actions of prolactin in the immune system. Proc Soc Exp Biol Med 1997;215:35-52.
55. Auernhammer CJ, Strasburger CJ. Effects of growth hormone and insulin like growth factor I on the immune system. Eur J Endocrinol 1995;133:635-45.
56. Galdiero M, Donnarumma G, Cipollano de L, Eru-G, Marcatili-A. Effect of growth hormone, protection and insulin on the release of IL-I alpha, IFN-gamma and IL-4 by staphylococcal enterotoxin A-stimulated splenocytes. Eur Cytokine Netw 1995;6:187-94.
57. Kelly KW, Brief S, Westly HJ, Novakofski J, Bechtel PJ, Simon J and Walker ER. Hormonal regulation of the age-associated decline in immune function. Ann N Y Acad Sci 1987;496:91-7.
58. Ellis LA, Mastro AM, Picciano MF. Do milk borne cytokines and hormones influence neonatal immune cell function? J Nutr 1997;127:985S-88S.
59. Kruger TE, Smith LR, Harbour DV, Blalock JE. Thyrotropin: An endogenous regulator of the in vitro immune response. J Immunol 1989;142:744-7.
60. Weigent DA, Carr DJJ, Blalock JE. Bidirectional communication between the neuroendocrine and immune system. Common hormones and hormone receptors. Ann N Y Acad Sci 1990;579:17-27.
61. Blalock JE. A molecular basis for bidirectional communication between the immune and neuroendocrine systems. Physiol Reviews 1989;69:1-32.
62. Berczi I. The pituitary-thyroid axis. In I. Berczi (eds.) Pituitary Function and Immunity. Boca Raton: CRC Press, 1986;213-9.
63. Ingram KG, Gouch DA, Douez DL, Goy BA, Woodward B. Effects of triiodothyronine supplements on splenic NK cells in malnourished weanling mice, Int J Immunopharmacol 1995;17:21-32.
64. Angstwurm MW, Gartner R, Ziegler-Heitbrock HW. Cyclic plasma IL-6 levels during normal menstrual cycle. Cytokine 1997;9:370-4.
65. Grossman CJ. Are there underlying immune neuroendocrine interactions responsible for immunological sexual dimorphism? Progress Neuro Endocr Immunol 1990;3:75-82.
66. Grossman CJ. Interactions between the gonadal steroids and the immune system. Science 1985;227:257-61.
67. Lahita RG. Predisposing factors to autoimmune disease. Int J Fertil Womens Med 1997;42:115-9.
68. Berczi I. Gonadotropins and sex hormones. In I. Berczi (ed.) Pituitary Function and Immunity. Boca Raton: CRC Press, 1986:185-211.
69. Josefsson E, Tarkowski A, Carlsten H. Anti inflammatory properties of estrogen - In vivo suppression of leukocyte production in bone marrow and redistribution of peripheral blood neutrophils. Cell Immunol 1992;142:67-78.
70. Pung OJ, Tucker AN, Vore SJ, Luster MI. Influence of estrogen on host resistance: increased susceptibility of mice to Listeria monocytogenes correlated with depressed production of interleukin 2. Infection Immunol 1985;50:91-6.
71. Christeff N, Lortholary D, Casassus P, Thobie N, Veyssier P, Torri O et al. Relationship between sex steroid hormone levels and CD4 lymphocytes in HIV infected man. Exp Clin Endocrin Diabetes 1996;104:130-6.
72. Provinciali M, Di-Stefano G, Muzzioli M, Garzetti GG, Ciavattini A, Fabris N. Relationship between 17-beta-estrodiol and prolactin in the regulation of NK cell activity during progression of endometriosis. J Endocrin Invest 1995;18:645-52.
73. Jessop DS, Harbuz MS, Snelson CL, Dayan CM, Lightman SL. An antisense oligodeoxynucleotide complementary to CRh mRNA inhibits rat splenocyte proliferation in vitro. J Neuroimmunol 1997;75:135-40.
74. Labeur MS, Arzt E, Wiegers GJ, Holsbour F, Reul JM. Long term intracerebroventicular corticotiopin releasing hormone administration induces distinct changes in rat splenocyte activation and cytokine expression. Endocrinol 1995;13696:2678-88.
75. Linthorst AC, Flachskamm C, Hopkins SJ et al. Long term intracerebroventricular infusion of CRH alters neuroendocrine, neurochemical, autonomic behavioural and cytokine responses to a systemic inflammatory challenge. J Neurosci 1997;17:4448-60.
76. Singh VK, Warren RP, White ED, Leu SJC. Corticotropinreleasing factor-induced stimulation of immune functions. Ann N Y Acad Sci 1990;594:416-9.
77. Karalis K, Muglia LJ, Bae D, Hilderbrand H, Majzoub JA, CRH and the immune system. J Neuroimmunol 1997,72:131-6.
78. Johnson HM, Smith EM, Torres BA, Blalock JE. Neuroendocrine hormone regulation of in vitro antibody production. Proc Natn Acad Sci USA 1982;79:4171-4.
79. Payan DG, McGillis JP, Goetzl E. Neuroimmunology Adv Immunol 1986;39:299-323.
80. Bateman A, Singh A, Kral T, Soloman S. The immunehypothalamic-pituitary-adrenal axis. Endocr Rev 1989;10:92-112.
81. Wick G, Hu Y, Schwarz S, Kroemer G immunoendocrine communication via the hypothalamus-pituitary-adrenal axis in autoimmune diseases. Endocr Rev 1993;14:240-56.
82. Wilckens T, De Rijk R. Glucocorticoids and immune function: unknown dimensions and new frontiers, Immunol Today 1997;18:418-24.
83. Conn LA. Glucocorticosteroids as immunosuppressive agents. Semin Vet Med Surg Small Anim 1997;12:150-6.
84. Cupps TR, Fauci AS. Corticosteroid mediated immunoregulation in man. Immunol Rev 1989;65:133-55.
85. Hall NR, Goldstein AL. Endocrine regulation of host immunity. In Fenichel RL and Chingos MA (eds.). Immune Modulation Agents and their mechanisms. New York: Dekker, 1984:533-63.
86. Calandra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, Donnelly T et al. MIF as a glucocorticoid induced modulator of cytokine production. Nature 1995;376:68-71.
87. Bakker JM, Schmidt Ed, Kroes H, Kavelaars A, Heijner CJ, Tilders FJ et al. Effects of short term dexamethasone treatment during pregnancy on the development of the immune system and the hypothalamo pituitary adrenal axis in the rat. J Neuroimmunol 1995;63:183-91.
88. Priddy KD. Immunologic adaptations during pregnancy. J Obstet Gynecol Neonatal Nurs 1997;26:388-94.
89. Philips A, Maira M, Mullick A, Chamberland M, Lesage S, Hugo P et al. Antagonism between Nurr 77 and glucocorticoid receptor for control of transcription. Mol Cell Biol 1997;17:5952-9.
90. Ronchetti S, Nocentini G, Giunchi L, Bartoli A, Moraca R, Riccardi C et al. Short term dexamethasone treatment modulates the expression of the munne TCR zeta gene locus. Cellular Immunol 1997;178:124-31.
91. Chancellor-Freeland C, Zhu GF, Kage R, Beller DI, Leeman SE, Black PH. Substance P stress induced changes in macrophages. Ann N Y Acad Sci 1995;771:472-84.
92. Hogaboam CM, Snider DP, Collins SM. Neuromuscular regulation of T cell activation. J Neuroimmunol 1997;75:123-312.
93. Johnson HM, Torres BA. Immunoregulatory properties of neuroendocrine peptide hormones. Progress Allergy 1988;43:37-67.
94. Payan DG. Substance P : A modulator of neuro endocrineimmune function. Hospital Practice 1989;24:67-80.
95. De la Fuente M, Delgado M, Gomariz RP. VIP modulation of immune cell functions. Adv Neuroimmunol 1996;6:75-91.
96. Bellinger DL, Lorton D, Brouxhon S, Felten S, Felten DL. The significant of VIP in immunomodulation, Adv Neuroimmunol 1996;6:5-27.
97. Kaltreider HB, Ichikawa S, Byrd PK, Ingram DA, Kishiyama JL, Sreedharan SP et al. Upregulation of neuropeptide receptors in a murine model of immune inflammation in lung parenchyma. Am J Respir Cell Mol Biol 1997:16:133-44.
98. Scully JL,Otten U. NGF: not just for neurons. Cell Biol Int 1995;19:459-69.
99. Brodie C, Oshiba A, Renz H, brodley K, Gelfand EW, NGF and anti CD40 provide opposite signals for the production of IgE in IL-4-treated lymphocytes. Eur J Immunol 1996;26:171-8.
100. Levi Montalcini R, Skaper SD, Dal Toso R, Petrelli L, Leon A. Nerve growth factor: from neurotrophin to neurokine. Trends Neurosci 1996;19:514-20.
101. Morch H, Pedersen BK. beta-endorphin and the immune system possible role in autoimmune diseases. Autoimmunity 1995;21:161-71.
102. Hsuch CM, Chen SF, Ghanta VK, Hiramoto RN. Expression of the conditioned NK cell activity is beta endorphin dependent. Brain Res 1995;678:76-82.
103. Straub RH, Herrmann M, Berkamiller G, Fraueholz T, Lang B, Scholmerich J et al. Neural regulation of IL-6 secretion in murine spleen: adrenergic and opioidergic control. J Neurochem 1997;68:1633-9.
104. Bajpai K, SinghVK, Dhawan VC, Haq W, Mathur KB, Agarwal SS. Immunomodulation by two potent analogs of metenkephalin. Immunopharmacol 1997;35:213-20.
105. Nair MP, Schwartz SA, Polasani R, Hou J, Sweet A, Chadha KC. Immunoregulatory effects of morphine on human lymphocytes. Clin Diagn Lab Immunol 1997;4:127-32.
106. Besedovsky HO, Sorkin E, Felix D, Hass H. Hypothalamic changes during the immune response. Eur J Immunol 1977;7:325-8.
107. Besedovsky HO, DelRay A, Sorkin E, DaPrada M, Burri R, Honegger C. The immune response evokes changes in brain noradrenergic neurons. Science 1983;221:564-5.
108. Carlson SL, Felten DL, Uvnat S, Felten SY. Alterations of monoamines in specific central autonomic nuclei following immunization in mice. Brain Behav Immun 1987;1:52-63.
109. Besedovsky HO, Sorkin E. Hormonal control of immune processes. Endocrinology 1977;2:504-13.
110. Besedovsky HO, Sorkin E, Keller M, Muller J. Changes in blood hormone levels during the immune response. Proc Soc Exp Biol Med 1975;150:466-70.
111. Besedovsky H, DelRay A, Sorkin E, Dinarello CA. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 1986;233:652-4.
112. Murphy PA, Simon PL, Willoughby WF. Endogenous pyrogens mode by rabbit peritoneal exudate cell are identical with lymphocyte-activating factors made by rabbit alveolar macrophages. J Immun 1980;124:2498-501.
113. Fauci AS. immunosuppressive and anti-inflammatory effects of glucocorticoids. In: Baxter, Rousseau, eds. Glucocorticoid hormone action. New York: Springer, 1979:449-65.
114. Woloski BMRNJ, Smith EM, Meyer WJ, Fuller GM, Blalock JE. Corticotropin-releasing activity of monokines. Science 1985;230:1035-7.
115. Berridge MJ, Irvine RF. Inositol triphosphate. A novel messenger in cellular signal transduction. Nature (Lond) 1984;312:315-21.
116. 2+ from a nonmitochondrial intracellular store in pancreatic acinar cells by inositol, 4,5,triphosphate. Nature (Lond) 1983;306:67-9.
117. Lichman AH, Segel GB, Lichtman MA. The role of calcium in lymphocyte proliferation (an interpretive review). Blood 1983;61:413-22.
118. Macara IG. Oncogenes, ions and phospholipids. Am J Physiol 1985;C248:C3-C11.
119. Majerus PW, Neufeld EJ, Wilson DB. Production of phosphoinositol-derived messengers. Cell 1984;37:701-3.
120. Coffey RG, Hadden JW. Neurotransmitters, hormones, and cyclic nucleotides in lymphocyte regulation. Fed Proc 1985;44:112-7.